Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Haploinsufficiency | 4 | 2022 | 72 | 1.610 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2025 | 849 | 1.140 |
Why?
|
| Chromosome Deletion | 4 | 2020 | 214 | 1.010 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2022 | 58 | 0.980 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2025 | 331 | 0.980 |
Why?
|
| Wnt Signaling Pathway | 2 | 2017 | 105 | 0.920 |
Why?
|
| Genes, APC | 2 | 2017 | 25 | 0.910 |
Why?
|
| Clathrin | 4 | 2011 | 33 | 0.760 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2017 | 385 | 0.760 |
Why?
|
| Bone Marrow | 2 | 2020 | 420 | 0.640 |
Why?
|
| Neoplasms, Second Primary | 3 | 2020 | 244 | 0.630 |
Why?
|
| Leukemia, Myeloid | 2 | 2020 | 241 | 0.600 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 136 | 0.600 |
Why?
|
| Genes, p53 | 2 | 2020 | 108 | 0.550 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2015 | 100 | 0.520 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 24 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 113 | 0.490 |
Why?
|
| Peptide Termination Factors | 1 | 2016 | 6 | 0.480 |
Why?
|
| Retroviridae | 1 | 2016 | 74 | 0.460 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 103 | 0.450 |
Why?
|
| Wnt Proteins | 1 | 2015 | 128 | 0.440 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2005 | 106 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 403 | 0.400 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 42 | 0.400 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 551 | 0.370 |
Why?
|
| Mice | 10 | 2025 | 12702 | 0.370 |
Why?
|
| Carrier Proteins | 1 | 2015 | 667 | 0.360 |
Why?
|
| Repressor Proteins | 2 | 2025 | 448 | 0.350 |
Why?
|
| Homeodomain Proteins | 2 | 2025 | 566 | 0.330 |
Why?
|
| B-Lymphocytes | 3 | 2005 | 727 | 0.330 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 137 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 462 | 0.320 |
Why?
|
| Proteins | 1 | 2016 | 803 | 0.320 |
Why?
|
| Ethylnitrosourea | 2 | 2022 | 30 | 0.290 |
Why?
|
| Animals | 13 | 2025 | 28907 | 0.270 |
Why?
|
| Inflammation | 2 | 2025 | 1122 | 0.260 |
Why?
|
| Membrane Microdomains | 3 | 2005 | 52 | 0.250 |
Why?
|
| Cell Plasticity | 1 | 2025 | 25 | 0.230 |
Why?
|
| Mutation | 1 | 2015 | 4396 | 0.200 |
Why?
|
| Antigens, CD34 | 1 | 2022 | 162 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3607 | 0.170 |
Why?
|
| Chromatin | 1 | 2024 | 454 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1605 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2020 | 153 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2025 | 2206 | 0.150 |
Why?
|
| Endocytosis | 2 | 2011 | 187 | 0.130 |
Why?
|
| Pyrvinium Compounds | 1 | 2017 | 6 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 55 | 0.130 |
Why?
|
| Humans | 13 | 2025 | 97979 | 0.130 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 217 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 618 | 0.110 |
Why?
|
| beta Catenin | 1 | 2017 | 267 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1254 | 0.110 |
Why?
|
| AT Rich Sequence | 1 | 2014 | 6 | 0.100 |
Why?
|
| Anemia, Macrocytic | 1 | 2013 | 4 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 21 | 0.100 |
Why?
|
| Biological Transport, Active | 2 | 2005 | 98 | 0.100 |
Why?
|
| Genes, Lethal | 1 | 2013 | 49 | 0.100 |
Why?
|
| Erythroblasts | 1 | 2013 | 27 | 0.100 |
Why?
|
| Erythropoiesis | 1 | 2013 | 53 | 0.100 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 33 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2014 | 121 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2024 | 1717 | 0.100 |
Why?
|
| Spleen | 1 | 2013 | 375 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2013 | 353 | 0.090 |
Why?
|
| Cell Line | 3 | 2014 | 2482 | 0.090 |
Why?
|
| Heterozygote | 1 | 2013 | 390 | 0.090 |
Why?
|
| Receptors, Growth Factor | 1 | 2011 | 52 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 461 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 80 | 0.080 |
Why?
|
| Alleles | 1 | 2013 | 1160 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2011 | 194 | 0.080 |
Why?
|
| Cytogenetic Analysis | 1 | 2009 | 70 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2573 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 731 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1133 | 0.070 |
Why?
|
| Histones | 1 | 2011 | 363 | 0.070 |
Why?
|
| Genotype | 1 | 2013 | 1888 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1110 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2855 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1646 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1752 | 0.060 |
Why?
|
| src-Family Kinases | 2 | 2004 | 70 | 0.060 |
Why?
|
| Antigen Presentation | 2 | 2004 | 234 | 0.050 |
Why?
|
| Actins | 2 | 2005 | 480 | 0.050 |
Why?
|
| Ligands | 2 | 2004 | 487 | 0.050 |
Why?
|
| Chickens | 1 | 2005 | 195 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 2638 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2004 | 136 | 0.050 |
Why?
|
| Aged | 1 | 2022 | 21737 | 0.050 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2024 | 79 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2004 | 1145 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 994 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 312 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2004 | 3623 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2024 | 332 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2024 | 298 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 750 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 13 | 0.030 |
Why?
|
| Granulocytes | 1 | 2014 | 34 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 256 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2014 | 187 | 0.020 |
Why?
|
| Male | 2 | 2015 | 47043 | 0.020 |
Why?
|
| Monocytes | 1 | 2014 | 219 | 0.020 |
Why?
|
| Female | 1 | 2015 | 51533 | 0.020 |
Why?
|
| Azo Compounds | 1 | 1989 | 14 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 1989 | 48 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1989 | 77 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1565 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2019 | 0.010 |
Why?
|
| Transferrin | 1 | 2004 | 19 | 0.010 |
Why?
|
| Immune Sera | 1 | 2004 | 48 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 89 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 218 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 447 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2892 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1989 | 83 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1989 | 119 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1989 | 418 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 945 | 0.000 |
Why?
|
| Kinetics | 1 | 1989 | 1476 | 0.000 |
Why?
|
| Rats | 1 | 1989 | 4070 | 0.000 |
Why?
|